378 related articles for article (PubMed ID: 24167019)
21. Prevalence and risk factors for allergic bronchopulmonary aspergillosis in Indian children with cystic fibrosis.
Sharma VK; Raj D; Xess I; Lodha R; Kabra SK
Indian Pediatr; 2014 Apr; 51(4):295-7. PubMed ID: 24825267
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
Voskamp AL; Gillman A; Symons K; Sandrini A; Rolland JM; O'Hehir RE; Douglass JA
J Allergy Clin Immunol Pract; 2015; 3(2):192-9. PubMed ID: 25640470
[TBL] [Abstract][Full Text] [Related]
23. Unusual clustering of allergic bronchopulmonary aspergillosis in children with cystic fibrosis.
Maguire S; Moriarty P; Tempany E; FitzGerald M
Pediatrics; 1988 Dec; 82(6):835-9. PubMed ID: 3186372
[TBL] [Abstract][Full Text] [Related]
24. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD010288. PubMed ID: 34550603
[TBL] [Abstract][Full Text] [Related]
25. Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis.
Koutsokera A; Corriveau S; Sykes J; Coriati A; Cortes D; Vadas P; Chaparro C; McIntyre K; Tullis E; Stephenson AL
J Cyst Fibros; 2020 Jan; 19(1):119-124. PubMed ID: 31405730
[TBL] [Abstract][Full Text] [Related]
26. A rare CFTR intronic mutation related to a mild CF disease in a 12-year-old girl.
Nathan N; Girodon E; Clement A; Corvol H
BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23144343
[TBL] [Abstract][Full Text] [Related]
27. Anti-IgE therapy for allergic bronchopulmonary aspergillosis.
Homma T; Kurokawa M; Matsukura S; Yamaguchi M; Adachi M
J Microbiol Immunol Infect; 2016 Jun; 49(3):459-63. PubMed ID: 24291616
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review.
Parisi GF; Portale A; Papale M; Tardino L; Rotolo N; Licari A; Leonardi S
J Allergy Clin Immunol Pract; 2019; 7(5):1636-1638. PubMed ID: 30772479
[No Abstract] [Full Text] [Related]
29. Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody.
Thomas MF
J R Soc Med; 2009 Jul; 102 Suppl 1(Suppl 1):49-53. PubMed ID: 19605876
[No Abstract] [Full Text] [Related]
30. Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
Li JX; Fan LC; Li MH; Cao WJ; Xu JF
Respir Med; 2017 Jan; 122():33-42. PubMed ID: 27993289
[TBL] [Abstract][Full Text] [Related]
31. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis.
Marchant JL; Warner JO; Bush A
Thorax; 1994 Oct; 49(10):1002-5. PubMed ID: 7974292
[TBL] [Abstract][Full Text] [Related]
32. Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus.
Barton RC; Hobson RP; Denton M; Peckham D; Brownlee K; Conway S; Kerr MA
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):287-91. PubMed ID: 18947811
[TBL] [Abstract][Full Text] [Related]
33. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology.
Nikolaizik WH; Moser M; Crameri R; Little S; Warner JO; Blaser K; Schöni MH
Am J Respir Crit Care Med; 1995 Aug; 152(2):634-9. PubMed ID: 7633719
[TBL] [Abstract][Full Text] [Related]
34. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
[TBL] [Abstract][Full Text] [Related]
35. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.
Thomson JM; Wesley A; Byrnes CA; Nixon GM
Pediatr Pulmonol; 2006 Feb; 41(2):164-70. PubMed ID: 16317722
[TBL] [Abstract][Full Text] [Related]
36. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis.
Chung Y; Kraut JR; Stone AM; Valaitis J
Pediatr Pulmonol; 1994 Feb; 17(2):131-4. PubMed ID: 8165040
[TBL] [Abstract][Full Text] [Related]
37. Allergic bronchopulmonary aspergillosis and omalizumab.
Tillie-Leblond I; Germaud P; Leroyer C; Tétu L; Girard F; Devouassoux G; Grignet JP; Prudhomme A; Dusser D; Wallaert B
Allergy; 2011 Sep; 66(9):1254-6. PubMed ID: 21517902
[No Abstract] [Full Text] [Related]
38. Potential role of the cellular allergen stimulation test (CAST) in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis.
Ringer S; Hipler UC; Elsner P; Zintl F; Mainz J
Pediatr Pulmonol; 2007 Apr; 42(4):314-8. PubMed ID: 17335008
[TBL] [Abstract][Full Text] [Related]
39. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
Moss RB
Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
[TBL] [Abstract][Full Text] [Related]
40. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis.
Latzin P; Hartl D; Regamey N; Frey U; Schoeni MH; Casaulta C
Eur Respir J; 2008 Jan; 31(1):36-42. PubMed ID: 17898016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
